@article{2503fba204e141b6891df7d037f78839,
title = "Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy",
keywords = "anti-CD20, autoimmune blistering disorder, monoclonal antibody, ocrelizumab, pemphigus vulgaris, rituximab",
author = "Gabrielle Benesh and Andriano, {Tyler M.} and Cohen, {Steven R.}",
note = "Funding Information: Author contributions: SRC and GB contributed to the conceptualization of the study. GB contributed to data collection. SRC, GB, and TA contributed to methodology, data curation and interpretation. All authors contributed to writing of the manuscript. Access to data and data analysis: SRC and GB had full access to all the data in the study and take responsibility for the integrity of the data. Funding sources: None.",
year = "2021",
month = oct,
doi = "10.1016/j.jdcr.2021.08.005",
language = "English (US)",
volume = "16",
pages = "12--15",
journal = "JAAD Case Reports",
issn = "2352-5126",
publisher = "Elsevier Inc.",
}